Decomit® HFA is a metered dose inhaler (MDI) contains beclomethasone dipropionate. It is environment friendly inhaler which contains ozone-benign propellant replacing CFC propellant. Decomit HFA is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Beclomethasone dipropionate is also indicated for asthma patients who require systemic corticosteroid administration, where adding Beclomethasone dipropionate may reduce or eliminate the need for the systemic corticosteroids.
Decomit 100 (HFA) Inhaler
৳ 270.00
Adults (including the elderly): The usual starting dose is 200 micrograms twice a day. In more severe cases the starting dose may need to increase to 600 to 800 micrograms per day which may then be reduced when the patient’s asthma has stabilised. The total daily dose may be administered as two, three, or four divided doses
Children: 50 to 100 micrograms should be given two, three or four times daily in accordance to the response. Alternatively, 100 micrograms or 200 micrograms twice daily should be given. The usual starting dose is 100 micrograms twice daily. Beclometasone 250 Inhaler is not recommended for children.
Beclometasone 250 HFA Inhaler: The usual starting dose is 200 micrograms twice a day. In more severe cases the starting dose may need to increase to 600 to 800 micrograms per day which may then be reduced when the patient’s asthma has stabilised. The total daily dose may be administered as two, three, or four divided doses.